WHWK
Price
$1.93
Change
+$0.03 (+1.58%)
Updated
Jun 27 closing price
Capitalization
90.92M
38 days until earnings call
WXIBF
Price
$3.18
Change
+$0.33 (+11.58%)
Updated
Jun 27 closing price
Capitalization
13.04B
Interact to see
Advertisement

WHWK vs WXIBF

Header iconWHWK vs WXIBF Comparison
Open Charts WHWK vs WXIBFBanner chart's image
Whitehawk Therapeutics
Price$1.93
Change+$0.03 (+1.58%)
Volume$146.58K
Capitalization90.92M
Wuxi Biologics Cayman
Price$3.18
Change+$0.33 (+11.58%)
Volume$300
Capitalization13.04B
WHWK vs WXIBF Comparison Chart in %
Loading...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
WHWK vs. WXIBF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is WHWK is a Buy and WXIBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (WHWK: $1.93 vs. WXIBF: $3.18)
Brand notoriety: WHWK and WXIBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: WHWK: 91% vs. WXIBF: 14%
Market capitalization -- WHWK: $90.92M vs. WXIBF: $13.04B
WHWK [@Biotechnology] is valued at $90.92M. WXIBF’s [@Biotechnology] market capitalization is $13.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

WHWK’s FA Score shows that 0 FA rating(s) are green whileWXIBF’s FA Score has 1 green FA rating(s).

  • WHWK’s FA Score: 0 green, 5 red.
  • WXIBF’s FA Score: 1 green, 4 red.
According to our system of comparison, WHWK is a better buy in the long-term than WXIBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

WHWK’s TA Score shows that 4 TA indicator(s) are bullish while WXIBF’s TA Score has 6 bullish TA indicator(s).

  • WHWK’s TA Score: 4 bullish, 3 bearish.
  • WXIBF’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, WXIBF is a better buy in the short-term than WHWK.

Price Growth

WHWK (@Biotechnology) experienced а -7.66% price change this week, while WXIBF (@Biotechnology) price change was -2.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

WHWK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXIBF($13B) has a higher market cap than WHWK($90.9M). WXIBF has higher P/E ratio than WHWK: WXIBF (29.26) vs WHWK (12.87). WXIBF YTD gains are higher at: 46.544 vs. WHWK (-38.827).
WHWKWXIBFWHWK / WXIBF
Capitalization90.9M13B1%
EBITDA27.9MN/A-
Gain YTD-38.82746.544-83%
P/E Ratio12.8729.2644%
Revenue27.8MN/A-
Total Cash231MN/A-
Total Debt0N/A-
FUNDAMENTALS RATINGS
WHWK vs WXIBF: Fundamental Ratings
WHWK
WXIBF
OUTLOOK RATING
1..100
3850
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
5061
PRICE GROWTH RATING
1..100
5740
P/E GROWTH RATING
1..100
388
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (45) in the Pharmaceuticals Major industry is in the same range as WXIBF (71) in the null industry. This means that WHWK’s stock grew similarly to WXIBF’s over the last 12 months.

WHWK's Profit vs Risk Rating (95) in the Pharmaceuticals Major industry is in the same range as WXIBF (100) in the null industry. This means that WHWK’s stock grew similarly to WXIBF’s over the last 12 months.

WHWK's SMR Rating (50) in the Pharmaceuticals Major industry is in the same range as WXIBF (61) in the null industry. This means that WHWK’s stock grew similarly to WXIBF’s over the last 12 months.

WXIBF's Price Growth Rating (40) in the null industry is in the same range as WHWK (57) in the Pharmaceuticals Major industry. This means that WXIBF’s stock grew similarly to WHWK’s over the last 12 months.

WXIBF's P/E Growth Rating (8) in the null industry is in the same range as WHWK (38) in the Pharmaceuticals Major industry. This means that WXIBF’s stock grew similarly to WHWK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
WHWKWXIBF
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
63%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCNE22.890.54
+2.42%
CNB Financial Corp
HSIC73.260.11
+0.15%
Henry Schein
MYGN5.26-0.06
-1.22%
Myriad Genetics
TIRX1.23-0.03
-2.38%
TIAN RUIXIANG Holdings Ltd
MTEN10.37-2.41
-18.86%
Mingteng International Corp

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been closely correlated with ELVAF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if WHWK jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
+1.58%
ELVAF - WHWK
76%
Closely correlated
N/A
DMAC - WHWK
42%
Loosely correlated
+0.79%
IPSC - WHWK
38%
Loosely correlated
-5.74%
CLYYF - WHWK
37%
Loosely correlated
N/A
BEAM - WHWK
35%
Loosely correlated
-1.98%
More

WXIBF and

Correlation & Price change

A.I.dvisor tells us that WXIBF and WXXWY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WXIBF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXIBF
1D Price
Change %
WXIBF100%
+11.58%
WXXWY - WXIBF
32%
Poorly correlated
N/A
IRON - WXIBF
28%
Poorly correlated
+0.68%
WHWK - WXIBF
24%
Poorly correlated
+1.58%
ELVAF - WXIBF
22%
Poorly correlated
N/A
KZR - WXIBF
20%
Poorly correlated
+3.98%
More